The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA

The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OAThe role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA, Published online: 11 May 2018; doi:10.1038/s41584-018-0010-zIn this Perspectives article, Roemer et al. argue that the time has come to use MRI, rather than radiography, as the primary imaging modality for defining eligibility criteria for clinical trials of potential disease-modifying osteoarthritis drugs (DMOADs).

Source: Nature Reviews Rheumatology - May 11, 2018 Category: Rheumatology Authors: Frank W. Roemer C. Kent Kwoh Daichi Hayashi David T. Felson Ali Guermazi Source Type: research